Multiple Sclerosis-Simvastatin Trial 2

Summary

Multiple Sclerosis-Simvastatin Trial 2 is a clinical trial^[1].

Key Facts

• Multiple Sclerosis-Simvastatin Trial 2 is in the country of Ireland^[2].
• Multiple Sclerosis-Simvastatin Trial 2 is in the country of United Kingdom^[3].
• Multiple Sclerosis-Simvastatin Trial 2's instance of is recorded as clinical trial^[4].
• Multiple Sclerosis-Simvastatin Trial 2's start time is recorded as +2018-03-28T00:00:00Z^[5].
• Multiple Sclerosis-Simvastatin Trial 2's end time is recorded as +2023-08-31T00:00:00Z^[6].
• Multiple Sclerosis-Simvastatin Trial 2's main subject is recorded as sclerosis^[7].
• Multiple Sclerosis-Simvastatin Trial 2's main subject is recorded as multiple sclerosis^[8].
• Multiple Sclerosis-Simvastatin Trial 2's number of participants is recorded as {'unit': '1', 'amount': '+1180'}^[9].
• Multiple Sclerosis-Simvastatin Trial 2's title is recorded as A Phase 3 Randomised, Double Blind, Clinical Trial Investigating the Effectiveness of Repurposed Simvastatin Compared to Placebo, in Secondary Progressive Multiple Sclerosis, in Slowing the Progression of Disability^[10].
• Multiple Sclerosis-Simvastatin Trial 2's short name is recorded as MS-STAT2^[11].
• Multiple Sclerosis-Simvastatin Trial 2's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+25'}^[12].
• Multiple Sclerosis-Simvastatin Trial 2's ClinicalTrials.gov ID is recorded as NCT03387670^[13].
• Multiple Sclerosis-Simvastatin Trial 2's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[14].
• Multiple Sclerosis-Simvastatin Trial 2's research intervention is recorded as simvastatin/sitagliptin^[15].
• Multiple Sclerosis-Simvastatin Trial 2's clinical trial phase is recorded as phase III clinical trial^[16].
• Multiple Sclerosis-Simvastatin Trial 2's research site is recorded as Royal Sussex County Hospital^[17].
• Multiple Sclerosis-Simvastatin Trial 2's research site is recorded as Cardiff University^[18].
• Multiple Sclerosis-Simvastatin Trial 2's research site is recorded as Royal Devon and Exeter Hospital^[19].
• Multiple Sclerosis-Simvastatin Trial 2's research site is recorded as Leeds General Infirmary^[20].
• Multiple Sclerosis-Simvastatin Trial 2's research site is recorded as Charing Cross Hospital^[21].
• Multiple Sclerosis-Simvastatin Trial 2's research site is recorded as University of London^[22].
• Multiple Sclerosis-Simvastatin Trial 2's research site is recorded as Royal Victoria Infirmary^[23].
• Multiple Sclerosis-Simvastatin Trial 2's research site is recorded as Queen's Medical Centre^[24].
• Multiple Sclerosis-Simvastatin Trial 2's research site is recorded as Derriford Hospital^[25].
• Multiple Sclerosis-Simvastatin Trial 2's research site is recorded as Royal Hallamshire Hospital^[26].